Krystal Biotech, Inc. · NASDAQ:KRYS

Krishnan Krish S sold 25,000 Krystal Biotech, Inc. shares (Form 4)

Traded Jun 4, 2026 · Filed Jun 5, 2026

On Jun 4, 2026, Krishnan Krish S (Director, President and CEO, 10% owner) sold 25,000 Krystal Biotech, Inc. shares at an average US$308.12 for US$7.7M under a trading plan, leaving 1,450,253 shares. Filed Jun 5, 2026 (Form 4).

Sold
25,000 shares
Price
US$308.12 average (US$300.75 to US$312.23)
Value
US$7.7M
Holding after
1,450,253 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, President and CEO, 10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 4, 2026Common StockSale320US$300.751,474,933Direct
Jun 4, 2026Common StockSale640US$302.241,474,293Direct
Jun 4, 2026Common StockSale176US$303.171,474,117Direct
Jun 4, 2026Common StockSale544US$304.811,473,573Direct
Jun 4, 2026Common StockSale589US$306.331,472,984Direct
Jun 4, 2026Common StockSale11,461US$307.681,461,523Direct
Jun 4, 2026Common StockSale4,830US$308.471,456,693Direct
Jun 4, 2026Common StockSale2,784US$309.491,453,909Direct
Jun 4, 2026Common StockSale2,652US$310.431,451,257Direct
Jun 4, 2026Common StockSale964US$311.361,450,293Direct
Jun 4, 2026Common StockSale40US$312.231,450,253Direct

Source

View original at SEC

Related